Rajasthan HC Orders Cyber Safety Reforms, Covering Influencer Rules and Aadhaar-Linked Digital IDs  ||  Bombay HC: SEBI Exercised Due Care and Caution in Approving the Wework India IPO Proposal  ||  Delhi HC: FEMA Summons Follow CPC, Not CrPC; ED May Call Women to Office For Statement Recording  ||  Kerala HC: Further Probe under Section 173(8) CrPC Allowed Only by Original Investigating Agency  ||  Delhi HC: Parties Must First Ask Social Media Platforms to Remove Content Before Seeking Injunction  ||  Supreme Court: Prosecutor Cannot Neglect Duty to Court in Pursuit of Securing Conviction  ||  Supreme Court: Selection Criteria Cannot be Altered After Interviews are Conducted  ||  NCLT Mumbai: Pending Cheque-Bounce Case Does not Prevent Admission of Insolvency Petition  ||  Kerala HC: Applications under the Muslim Women’s Divorce Act Have a 3-Year Limitation Period  ||  Supreme Court: Property Transferred Before Filing a Suit Cannot be Attached under Order 38 Rule 5    

Drugs and Cosmetics (Amendment) Bill, 2015 - (30 Nov 2015)

Miscellaneous

The Drugs and Cosmetics (Amendment) Bill, 2015, set to be introduced in the Parliament’s Winter Session, 2015, proposes much needed updates to the Drugs and Cosmetics Act, 1940. The Bill, 2015 broadens the scope of the government’s powers and introduces checks and balances in the manufacture, import, distribution and sale of drugs and cosmetics in India. Clinical trials are set to be overseen by the Ethics Committee, constituted under the Bill. The Committee will also have powers to audit clinical trials and make site visits to ensure safety and well being of participants. Greater regulation and oversight, stricter punishments and vigilance outline the proactive stance the Bill proposes for the government.

Tags : DRUG AND COSMETICS   BILL   2015   ETHICS COMMITTEE  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved